Atricure to participate in the goldman sachs 46th annual global healthcare conference

Mason, ohio--(business wire)--atricure, inc. (nasdaq: atrc), a leading innovator in surgical treatments and therapies for atrial fibrillation (afib), left atrial appendage (laa) management, and post-operative pain management, today announced that the company will be participating in the upcoming goldman sachs 46th annual global healthcare conference. atricure's management is scheduled to host a fireside chat on monday, june 9, 2025, at 4:00 p.m. eastern standard time. interested parties may acc.
ATRC Ratings Summary
ATRC Quant Ranking